Journal of Antimicrobial Chemotherapy, 0305-7453

Journal

Publications

  1. Published
  2. E-pub ahead of print
  3. Published
  4. Published

    Role of bacterial efflux pumps in biofilm formation

    1 Aug 2018, In : Journal of Antimicrobial Chemotherapy. 73, 8, p. 2003-2020 18 p.

    Research output: Contribution to journalReview article

  5. Published
  6. Published

    CTX-M extended-spectrum beta-lactamase arrives in the UK

    Peter Hawkey, 1 Feb 2003, In : Journal of Antimicrobial Chemotherapy. 51, 2, p. 470-1 2 p.

    Research output: Contribution to journalArticle

  7. Published
  8. Published
  9. Published
  10. E-pub ahead of print
  11. Published
  12. Published

    An investigation of the hydrophobicity of the quinolones

    Laura Piddock, Dec 1985, In : Journal of Antimicrobial Chemotherapy. 16, 6, p. 805-8 4 p.

    Research output: Contribution to journalArticle

  13. Published
  14. Published
  15. Published
  16. Published

    Inhibition of multidrug efflux as a strategy to prevent biofilm formation

    Laura Piddock & Mark Webber, Mar 2014, In : Journal of Antimicrobial Chemotherapy. 69, 3, p. 673-681 9 p.

    Research output: Contribution to journalArticle

  17. Published
  18. Published
  19. Published

    Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype

    Peter Hawkey, 1 Aug 2017, In : Journal of Antimicrobial Chemotherapy. 72, 8, p. 2145-2155 11 p.

    Research output: Contribution to journalReview article

  20. Published
  21. Published
  22. Published
  23. Published
  24. Published

    Effects of selective digestive decontamination (SDD) on the gut resistome

    Willem van Schaik, 1 Aug 2014, In : Journal of Antimicrobial Chemotherapy. 69, 8, p. 2215-23 9 p.

    Research output: Contribution to journalArticle

  25. Published
  26. Published
  27. Published
  28. Published
  29. Published
  30. Published

    The accumulation of five quinolone antibacterial agents by Escherichia coli

    Laura Piddock, Mar 1990, In : Journal of Antimicrobial Chemotherapy. 25, 3, p. 319-33 15 p.

    Research output: Contribution to journalArticle

  31. Published
  32. Published

    Antibiotics for community-acquired pneumonia

    Laura Piddock, Dec 2009, In : Journal of Antimicrobial Chemotherapy. 64, 6, p. 1123-5 3 p.

    Research output: Contribution to journalArticle

  33. Published
  34. Published

    Fluoroquinolone resistance in Haemophilus influenzae

    Laura Piddock, Oct 2003, In : Journal of Antimicrobial Chemotherapy. 52, 4, p. 734-5 2 p.

    Research output: Contribution to journalArticle

  35. Published
  36. Published
  37. Published
  38. Published
  39. E-pub ahead of print
  40. Published
  41. Published
  42. Published
  43. Published
  44. Published
  45. Published
  46. Published
  47. E-pub ahead of print
  48. Published
  49. Published

    Quinolone resistance in veterinary isolates of Salmonella

    Deborah Griggs & Laura Piddock, Jun 1994, In : Journal of Antimicrobial Chemotherapy. 33, 6, p. 1173-89 17 p.

    Research output: Contribution to journalArticle

  50. Published
  51. Published

    The killing action of fleroxacin upon Bacteroides fragilis

    Deborah Griggs, Laura Piddock, Jan 1989, In : Journal of Antimicrobial Chemotherapy. 23, 1, p. 53-8 6 p.

    Research output: Contribution to journalArticle

  52. Published
  53. Published

    Pre-clinical experience with daptomycin.

    Peter Hawkey, 1 Nov 2008, In : Journal of Antimicrobial Chemotherapy. 62 Suppl 3, p. iii7-14

    Research output: Contribution to journalArticle

  54. Published
  55. Published

    The growing burden of antimicrobial resistance

    Peter Hawkey, 1 Sep 2008, In : Journal of Antimicrobial Chemotherapy. 62 Suppl 1, p. i1-9

    Research output: Contribution to journalArticle

  56. Published

    The 2017 Garrod Lecture: genes, guts and globalization

    Peter Hawkey, 1 Oct 2018, In : Journal of Antimicrobial Chemotherapy. 73, 10, p. 2589–2600 12 p.

    Research output: Contribution to journalSpecial issue

  57. Published

    Genes, guts and globalisation

    Peter Hawkey, 1 Oct 2018, In : Journal of Antimicrobial Chemotherapy. p. 2589-2600 2600 p.

    Research output: Contribution to journalArticle

  58. Published

    Mechanisms of quinolone action and microbial response

    Peter Hawkey, 1 May 2003, In : Journal of Antimicrobial Chemotherapy. 51, 90001, p. 29-35 7 p.

    Research output: Contribution to journalReview article

  59. Published

    Antibiotic prescribing for the older adult: beliefs and practices in primary care

    Dan Lasserson, 1 Mar 2019, In : Journal of Antimicrobial Chemotherapy. 74, 3, p. 791-797 7 p.

    Research output: Contribution to journalArticle

  60. Published
  61. Published
  62. Published
  63. Published
  64. Published
  65. E-pub ahead of print
  66. Published
  67. Published
  68. E-pub ahead of print
  69. Published
  70. Published
  71. Published
  72. Published

    CTX-M: Changing the face of ESBLs in the UK

    Peter Hawkey, 1 Jan 2005, In : Journal of Antimicrobial Chemotherapy. p. 451-54 4 p.

    Research output: Contribution to journalArticle

  73. Published

    Discovery research: the scientific challenge of finding new antibiotics

    Laura Piddock, Sep 2011, In : Journal of Antimicrobial Chemotherapy. 66, 9, p. 1941-4 4 p.

    Research output: Contribution to journalArticle

  74. Published
  75. E-pub ahead of print
  76. Published

    Interaction of divalent cations, quinolones and bacteria

    Laura Piddock, Oct 1994, In : Journal of Antimicrobial Chemotherapy. 34, 4, p. 465-83 19 p.

    Research output: Contribution to journalArticle

  77. Published

    CTX-M ESBL-producing Enterobacteriaceae: estimated prevalence in adults in England in 2014

    Peter Hawkey, 1 May 2018, In : Journal of Antimicrobial Chemotherapy. 73, 5, p. 1368-1388 21 p.

    Research output: Contribution to journalArticle

  78. Published
  79. Published
  80. Published
  81. Published
  82. E-pub ahead of print
  83. Published
  84. Published
  85. Published
  86. Published
  87. Published
  88. Published

    Mechanisms of resistance to quinolones and clinical perspectives

    Laura Piddock, Apr 1989, In : Journal of Antimicrobial Chemotherapy. 23, 4, p. 475-80 6 p.

    Research output: Contribution to journalArticle

  89. Published

    Selection and characterization of cefepime-resistant gram-negative bacteria

    Laura Piddock & Deborah Griggs, Nov 1991, In : Journal of Antimicrobial Chemotherapy. 28, 5, p. 669-76 8 p.

    Research output: Contribution to journalArticle

  90. Published

    High-level quinolone resistance in Pseudomonas aeruginosa

    Laura Piddock & Peter Hawkey, Aug 1992, In : Journal of Antimicrobial Chemotherapy. 30, 2, p. 229-31 3 p.

    Research output: Contribution to journalArticle

  91. Published
  92. Published
  93. Published

    Teixobactin, the first of a new class of antibiotics discovered by iChip technology?

    Laura Piddock, Oct 2015, In : Journal of Antimicrobial Chemotherapy. 70, 10, p. 2679-80 2 p.

    Research output: Contribution to journalArticle

  94. Published
  95. Published
  96. Published
  97. Published

    The PBPs of Bacteroides fragilis

    Laura Piddock, Sep 1983, In : Journal of Antimicrobial Chemotherapy. 12, 3, p. 292

    Research output: Contribution to journalArticle

  98. Published
  99. Published
  100. Published
Previous 1 2 Next